Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections

• Main Authors: Goeun Choi (Author), Huiyan Piao (Author), N. Sanoj Rejinold (Author), Seungjin Yu (Author), Ki-yeok Kim (Author), Geun-woo Jin (Author), Jin-Ho Choy (Author)
• Format: Book
• Published: MDPI AG, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

COVID-19 has been affecting millions of individuals worldwide and, thus far, there is no accurate therapeutic strategy. This critical situation necessitates novel formulations for already existing, FDA approved, but poorly absorbable drug candidates, such as niclosamide (NIC), which is of great rele...